Aggregated
33% success rate- Bullish
- 0
- Hold
- 2
- Bearish
- 0
Goldman Sachs
A Goldman Sachs analyst with 30 tracked ratings across 18 distinct tickers has a 36.4% success rate on the captured sample, with a focus on both bullish and bearish positions.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| BCAX | 2026-05-12 | hold | $18.00 | Aggregated |
| RCUS | 2026-05-07 | buy | $34.00 | Aggregated |
| VRDN | 2026-04-07 | buy | $31.00 | Aggregated |
| BCAX | 2026-03-31 | hold | $16.00 | Aggregated |
| VRDN | 2026-03-31 | buy | $36.00 | Aggregated |
| PTGX | 2026-03-03 | hold | $95.00 | Aggregated |
| CLDX | 2026-03-02 | hold | $34.00 | Aggregated |
| RCKT | 2026-03-02 | sell | $3.00 | Aggregated |
| MLTX | 2026-01-15 | sell | $10.00 | Aggregated |
| RCUS | 2026-01-13 | buy | $28.00 | Aggregated |
| NUVL | 2025-11-18 | buy | $135.00 | Aggregated |
| ARQT | 2025-10-30 | hold | $29.00 | Aggregated |
| MLYS | 2025-09-09 | buy | $52.00 | Aggregated |
| MLYSMINERALYS THERAPEUTICS INC | 2025-09-09 | unknown | $52.00 | Aggregated |
| VRDN | 2025-08-07 | buy | $30.00 | Aggregated |
| MLTX | 2025-08-06 | buy | $82.00 | Aggregated |
| MLTXMOONLAKE IMMUNOTHERAPEUTICS - ORDINARY SHARES - CLASS A | 2025-08-06 | unknown | $82.00 | Aggregated |
| ARQT | 2025-07-25 | hold | $18.00 | Aggregated |
| OLMAOLEMA PHARMACEUTICALS INC | 2025-05-14 | unknown | $18.00 | Aggregated |
| CLDX | 2025-05-09 | hold | $31.00 | Aggregated |
| SLN | 2025-05-09 | sell | $3.00 | Aggregated |
| VRDNVIRIDIAN THERAPEUTICS INC | 2025-05-07 | unknown | $27.00 | Aggregated |
| VKTX | 2025-04-08 | hold | $30.00 | Aggregated |
| SLN | 2025-03-04 | sell | $4.00 | Aggregated |
| CLDX | 2025-03-03 | hold | $36.00 | Aggregated |
| CLDXCELLDEX THERAPEUTICS INC. | 2025-03-03 | hold | $36.00 | Aggregated |
| RCKTROCKET PHARMACEUTICALS INC | 2025-03-03 | hold | $15.00 | Aggregated |
| MLYS | 2025-02-13 | buy | $24.00 | Aggregated |
| SLN | 2025-02-11 | sell | $6.00 | Aggregated |
| MLYS | 2024-04-02 | buy | $30.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| BCAX | 2 | 2026-05-12 | Aggregated |
| RCUS | 2 | 2026-05-07 | Aggregated |
| VRDN | 3 | 2026-04-07 | Aggregated |
| PTGX | 1 | 2026-03-03 | Aggregated |
| CLDX | 3 | 2026-03-02 | Aggregated |
| RCKT | 1 | 2026-03-02 | Aggregated |
| MLTX | 2 | 2026-01-15 | Aggregated |
| NUVL | 1 | 2025-11-18 | Aggregated |
| ARQT | 2 | 2025-10-30 | Aggregated |
| MLYS | 3 | 2025-09-09 | Aggregated |
| MLYSMINERALYS THERAPEUTICS INC | 1 | 2025-09-09 | Aggregated |
| MLTXMOONLAKE IMMUNOTHERAPEUTICS - ORDINARY SHARES - CLASS A | 1 | 2025-08-06 | Aggregated |
| OLMAOLEMA PHARMACEUTICALS INC | 1 | 2025-05-14 | Aggregated |
| SLN | 3 | 2025-05-09 | Aggregated |
| VRDNVIRIDIAN THERAPEUTICS INC | 1 | 2025-05-07 | Aggregated |
| VKTX | 1 | 2025-04-08 | Aggregated |
| CLDXCELLDEX THERAPEUTICS INC. | 1 | 2025-03-03 | Aggregated |
| RCKTROCKET PHARMACEUTICALS INC | 1 | 2025-03-03 | Aggregated |